T1	Intervention 803 877	SAR patients were identified by history, skin-prick test and specific IgE.
T2	Intervention 1165 1267	After a washout period of at least 4 weeks, the procedure was repeated with placebo challenge (diluent
T3	Intervention 1001 1163	Sputum cells and supernatant levels of ECP, sICAM, IL-5 and IL-10, and plasma levels of IL-5 and ECP, were measured before and 24 h after nasal allergen challenge
